| Basic data
|
(21) | Request Number: | S20210010A (Request for grant of Supplementary Protection Certificate pending) |
(22) | Request Date: | 02.06.2021 |
(43) | Request Publication Date: | 25.06.2021 |
|
(71) | Applicant(s): | 1. | Novo Nordisk Health Care AG, The Circle 32/38, 8058 Zürich, CH |
|
(74) | Representative: | Vukmir i suradnici odvjetničko društvo d.o.o., Gramača 2L, 10000 Zagreb, HR
|
|
(68) | Basic Patent Number: | P20191521 |
(21) | Application Number | P20191521A |
(22) | Filing Date | 22.08.2019 |
(54) | Title of Invention: | GROWTH HORMONES WITH PROLONGED IN-VIVO EFFICACY |
|
(95) | Product Name: | SOMAPACITAN |
|
(92)(93) | Number and Date of First Marketing Authorisation: | EU/1/20/1501, 06.04.2021 td> |
|
|
|